Skip to main content
SpringerLink
Log in

Fungal Infections (Onychomycosis, Tinea Pedis, Tinea Cruris, Tinea Capitis, Tinea Manuum, Tinea Corporis, different Candida Infections, and Pityriasis Versicolor) and Mycological Laboratory Analyses

  • Chapter
  • First Online:
Gender and Dermatology

Abstract

This chapter deals with superficial fungal infections from the scope of gender dermatology. Onychomycosis occurs in both sexes, but it is more common in males. While generally more effective than topical treatment for onychomycosis, systemic treatment should be avoided in pregnancy and its use is limited due to drug-drug interactions and potential side effects. Tinea pedis is three times more frequent in males due to habitual and occupational differences. Tinea cruris is almost exclusively found in males because of the humidity created by the scrotum. Tinea capitis is seen in children without gender differences and warrants systemic treatment. Tinea manuum is a rare fungal infection of the palms that tends to be unilateral and warrants systemic treatment. Dermatophytosis of the body has different clinical types that are described in the chapter. The chapter also discusses different clinical types of cutaneous and genital candidiasis which is the leading cause of fungal infections worldwide. The chapter concludes with pityriasis versicolor and mycological laboratory analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43(2 Pt 1):244–8.

    Article  CAS  PubMed  Google Scholar 

  2. Ellabib MS, Agaj M, Khalifa Z, Kavanagh K. Yeasts of the genus Candida are the dominant cause of onychomycosis in Libyan women but not men: results of a 2-year surveillance study. Br J Dermatol. 2002;146(6):1038–41.

    Article  CAS  PubMed  Google Scholar 

  3. Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev. 1998;11(3):415–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol. 1997;133(9):1172–3.

    Article  CAS  PubMed  Google Scholar 

  5. Sigurgeirsson B, Baran R. The prevalence of onychomycosis in the global population: a literature study. J Eur Acad Dermatol Venereol. 2014;28(11):1480–91.

    Article  CAS  PubMed  Google Scholar 

  6. Rossaneis MA, Haddad Mdo C, Mathias TA, Marcon SS. Differences in foot self-care and lifestyle between men and women with diabetes mellitus. Rev Lat Am Enfermagem. 2016;24:e2761.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Avner S, Nir N, Henri T. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis. J Eur Acad Dermatol Venereol. 2006;20(10):1194–6.

    Article  CAS  PubMed  Google Scholar 

  8. Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol. 2004;150(3):537–44.

    Article  CAS  PubMed  Google Scholar 

  9. Segal R, Shemer A, Hochberg M, Keness Y, Shvarzman R, Mandelblat M, Frenkel M, Segal E. Onychomycosis in Israel: epidemiological aspects. Mycoses. 2015;58(3):133–9.

    Article  CAS  PubMed  Google Scholar 

  10. Gupta AK, De Doncker P, Haneke E. Itraconazole pulse therapy for the treatment of Candida onychomycosis. J Eur Acad Dermatol Venereol. 2001;15(2):112–5.

    Article  CAS  PubMed  Google Scholar 

  11. Gupta AK, Gregurek-Novak T, Konnikov N, Lynde CW, Hofstader S, Summerbell RC. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. J Cutan Med Surg. 2001;5(3):206–10.

    Article  CAS  PubMed  Google Scholar 

  12. Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, Shupack JL, Pinnell S, Levine N, Lowe NJ, Aly R, Odom RB, Greer DL, Morman MR, Bucko AD, Tschen EH, Elewski BE, Smith EB. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998;38(6 Pt 2):S77–86.

    Article  CAS  PubMed  Google Scholar 

  13. Food, Drug Administration HHS. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final Rule Fed Regist. 2014;79(233):72063–103.

    Google Scholar 

  14. Del Rosso JQ. Application of nail polish during topical management of onychomycosis: are data available to guide the clinician about what to tell their patients? J Clin Aesthet Dermatol. 2016;9(8):29–36.

    PubMed  PubMed Central  Google Scholar 

  15. Rosen T. Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10. Cutis. 2015;96(3):197–201.

    PubMed  Google Scholar 

  16. Ilkit M, Tanir F, Hazar S, Gumusay T, Akbab M. Epidemiology of tinea pedis and toenail tinea unguium in worshippers in the mosques in Adana. Turkey J Dermatol. 2005;32(9):698–704.

    Article  PubMed  Google Scholar 

  17. Cheng S, Chong L. A prospective epidemiological study on tinea pedis and onychomycosis in Hong Kong. Chin Med J. 2002;115(6):860–5.

    PubMed  Google Scholar 

  18. Kamihama T, Kimura T, Hosokawa JI, Ueji M, Takase T, Tagami K. Tinea pedis outbreak in swimming pools in Japan. Public Health. 1997;111(4):249–53.

    Article  CAS  PubMed  Google Scholar 

  19. Aste N, Pau M, Aste N, Biggio P. Tinea pedis observed in Cagliari, Italy, between 1996 and 2000. Mycoses. 2003;46(1-2):38–41.

    Article  CAS  PubMed  Google Scholar 

  20. Vella Zahra L, Gatt P, Boffa MJ, Borg E, Mifsud E, Scerri L, Vella Briffa D, Pace JL. Characteristics of superficial mycoses in Malta. Int J Dermatol. 2003;42(4):265–71.

    Article  PubMed  Google Scholar 

  21. al-Sogair SM, Moawad MK, al-Humaidan YM. Fungal infection as a cause of skin disease in the eastern province of Saudi Arabia: tinea corporis and tinea cruris. Mycoses. 1991;34(9-10):423–7.

    Article  CAS  PubMed  Google Scholar 

  22. Imwidthaya S, Thianprasit M. A study of dermatophytoses in Bangkok (Thailand). Mycopathologia. 1988;102(1):13–6.

    Article  CAS  PubMed  Google Scholar 

  23. Odom R. Pathophysiology of dermatophyte infections. J Am Acad Dermatol. 1993;28(5 Pt 1):S2–7.

    Article  CAS  PubMed  Google Scholar 

  24. Blank F, Mann SJ. Trichophyton rubrum infections according to age, anatomical distribution and sex. Br J Dermatol. 1975;92(2):171–4.

    Article  CAS  PubMed  Google Scholar 

  25. Blank F, Mann SJ, Reale RA. Distribution of dermatophytosis according to age, ethnic group and sex. Sabouraudia. 1974;12(3):352–61.

    Article  CAS  PubMed  Google Scholar 

  26. Otero L, Palacio V, Vazquez F. Tinea cruris in female prostitutes. Mycopathologia. 2002;153(1):29–31.

    Article  CAS  PubMed  Google Scholar 

  27. Shemer A, Plotnik IB, Davidovici B, Grunwald MH, Magun R, Amichai B. Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study. J Dtsch Dermatol Ges. 2013;11(8):737–41. 737-42

    PubMed  Google Scholar 

  28. Aste N, Pau M, Biggio P. Tinea capitis in adults. Mycoses. 1996;39(7-8):299–301.

    Article  CAS  PubMed  Google Scholar 

  29. Lopez-Gomez S, Del Palacio A, Van Cutsem J, Soledad Cuetara M, Iglesias L, Rodriguez-Noriega A. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol. 1994;33(10):743–7.

    Article  CAS  PubMed  Google Scholar 

  30. Gonzalez U, Seaton T, Bergus G, Jacobson J, Martinez-Monzon C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007;4:CD004685.

    Google Scholar 

  31. Chen X, Jiang X, Yang M, Bennett C, Gonzalez U, Lin X, Hua X, Xue S, Zhang M. Systemic antifungal therapy for tinea capitis in children: an abridged Cochrane review. J Am Acad Dermatol. 2017;76(2):368–74.

    Article  PubMed  Google Scholar 

  32. Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol. 2011;28(6):655–7.

    Article  PubMed  Google Scholar 

  33. Daniel CR 3rd, Gupta AK, Daniel MP, Daniel CM. Two feet-one hand syndrome: a retrospective multicenter survey. Int J Dermatol. 1997;36(9):658–60.

    Article  PubMed  Google Scholar 

  34. Ohno S, Tanabe H, Kawasaki M, Horiguchi Y. Tinea corporis with acute inflammation caused by Trichophyton tonsurans. J Dermatol. 2008;35(9):590–3.

    Article  PubMed  Google Scholar 

  35. Elgart ML. Tinea incognito: an update on Majocchi granuloma. Dermatol Clin. 1996;14(1):51–5.

    Article  CAS  PubMed  Google Scholar 

  36. Sneppen I, Thorup J. Foreskin morbidity in uncircumcised males. Pediatrics. 2016;137(5):e20154340. https://doi.org/10.1542/peds.2015-4340.

    Article  PubMed  Google Scholar 

  37. Terragni L, Lasagni A, Oriani A, Gelmetti C. Pityriasis versicolor in the pediatric age. Pediatr Dermatol. 1991;8(1):9–12.

    Article  CAS  PubMed  Google Scholar 

  38. Sunenshine PJ, Schwartz RA, Janniger CK. Tinea versicolor. Int J Dermatol. 1998;37(9):648–55.

    Article  CAS  PubMed  Google Scholar 

  39. Wyre HW Jr, Johnson WT. Neonatal pityriasis versicolor. Arch Dermatol. 1981;117(11):752–3.

    Article  PubMed  Google Scholar 

  40. Jubert E, Martin-Santiago A, Bernardino M, Bauza A. Neonatal pityriasis versicolor. Pediatr Infect Dis J. 2015;34(3):329–30.

    Article  PubMed  Google Scholar 

  41. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol. 2004;51(5):785–98.

    Article  PubMed  Google Scholar 

  42. Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106–41.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Mendez-Tovar LJ. Pathogenesis of dermatophytosis and tinea versicolor. Clin Dermatol. 2010;28(2):185–9.

    Article  PubMed  Google Scholar 

  44. He SM, Du WD, Yang S, Zhou SM, Li W, Wang J, Xiao FL, Xu SX, Zhang XJ. The genetic epidemiology of tinea versicolor in China. Mycoses. 2008;51(1):55–62.

    PubMed  Google Scholar 

  45. Shi TW, Ren XK, Yu HX, Tang YB. Roles of adapalene in the treatment of pityriasis versicolor. Dermatology. 2012;224(2):184–8.

    Article  CAS  PubMed  Google Scholar 

  46. Shi TW, Zhang JA, Tang YB, Yu HX, Li ZG, Yu JB. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor. J Dermatolog Treat. 2015;26(2):143–6.

    Article  CAS  PubMed  Google Scholar 

  47. Rivard SC. Pityriasis versicolor: avoiding pitfalls in disease diagnosis and therapy. Mil Med. 2013;178(8):904–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel

    Avner Shemer

  2. Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel

    Avner Shemer

  3. Division of Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

    Meir Babaev

Authors
  1. Avner Shemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meir Babaev
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tel Aviv University, Tel Aviv, Israel

    Ethel Tur

  2. Department of Dermatology, UCSF Medical Center, San Francisco, California, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shemer, A., Babaev, M. (2018). Fungal Infections (Onychomycosis, Tinea Pedis, Tinea Cruris, Tinea Capitis, Tinea Manuum, Tinea Corporis, different Candida Infections, and Pityriasis Versicolor) and Mycological Laboratory Analyses. In: Tur, E., Maibach, H. (eds) Gender and Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-72156-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72156-9_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72155-2

  • Online ISBN: 978-3-319-72156-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation